Valuation: Precipio, Inc.

Market Cap 45.15M 39.47M 36.27M 33.81M 64.13M 4.3B 65.1M 435M 169M 2.11B 169M 166M 7.28B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 46.15M 40.35M 37.08M 34.56M 65.55M 4.39B 66.55M 445M 173M 2.16B 173M 170M 7.44B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.41%
Yield 2024 *
-
Yield 2025 -
1 day+1.32%
1 week+12.74%
Current month+2.02%
1 month+12.37%
3 months-0.55%
6 months+6.05%
Current year+9.92%
1 week 22.26
Extreme 22.26
25.94
1 month 21.37
Extreme 21.3715
25.94
Current year 19.52
Extreme 19.52
33.63
1 year 12.46
Extreme 12.46
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Executive Officer 54 27/06/2017
Director of Finance/CFO 59 20/03/2022
Chief Tech/Sci/R&D Officer 42 31/05/2017
Director TitleAgeSince
Director/Board Member 54 27/06/2017
Director/Board Member 78 25/09/2017
Director/Board Member 67 07/11/2017
Date Insider Type Main position Quantity % Market Cap.
05-20Sell

Chairman

-900 0.0505%
05-19Sell

Chairman

-2,534 0.1421%
04-14Free

Director

365 0.0208%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+12.74%+123.60%+223.85% 45.15M
-1.95%-1.56%+1.21%-28.54% 16.67B
+5.89%+17.22%+43.79%+99.43% 1.68B
+0.39%+34.99%-39.53%-77.97% 1.24B
+0.06%+3.18%-28.32%+31.12% 1.14B
+1.31%-0.09%-25.81%-52.92% 631M
+0.21%-0.98%-39.13%-56.82% 580M
-0.66%+3.11%+21.67%-54.99% 447M
+1.79%-1.42%-55.45%-60.47% 375M
+2.52%+5.48%-20.26%-20.26% 353M
Average +1.18%+7.17%-1.82%+0.24% 2.32B
Weighted average by Cap. -0.96%+3.71%-1.69%-20.75%

Financials

2024 2025
Net sales 18.53M 16.2M 14.89M 13.88M 26.32M 1.76B 26.72M 179M 69.48M 867M 69.56M 68.07M 2.99B 24.05M 21.02M 19.32M 18.01M 34.16M 2.29B 34.68M 232M 90.17M 1.13B 90.27M 88.33M 3.88B
Net income -4.29M -3.75M -3.45M -3.21M -6.09M -408M -6.19M -41.38M -16.08M -201M -16.1M -15.76M -692M -363K -317K -292K -272K -516K -34.56M -523K -3.5M -1.36M -16.99M -1.36M -1.33M -58.54M
Net Debt -136K -119K -109K -102K -193K -12.95M -196K -1.31M -510K -6.37M -510K -500K -21.93M 1M 876K 805K 750K 1.42M 95.4M 1.44M 9.66M 3.76M 46.9M 3.76M 3.68M 162M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
02/07/26 US$25.26 +1.32% 6,893
01/07/26 US$24.93 +0.69% 12,651
30/06/26 US$24.76 +1.98% 16,216
29/06/26 US$24.28 +4.16% 5,250
26/06/26 US$23.31 +4.04% 54,316
  1. Stock Market
  2. Stocks
  3. PRPO Stock